Michael Richman

Mr. Michael S.
Richman is a President, Chief Executive Officer & Director at NextCure, Inc. He is on the Board of Directors at NextCure, Inc. Mr. Richman was previously employed as a Chairman by GenVec, Inc., an Independent Director by Pieris Pharmaceuticals, Inc., a Member-Supervisory Board by Pieris AG, a President & Chief Executive Officer by Amplimmune, Inc., an Independent Director by Opexa Therapeutics, Inc., a Chief Operating Officer & Executive Vice President by MacroGenics, Inc., a SVP-Corporate Development & Administration by MedImmune LLC, and a Director-Corporate Business Development by Chiron Corp.
He also served on the board at Madison Vaccines, Inc., PharmaFrontiers Corp., Cougar Biotechnology, Inc. and Cougar Biotechnology, Inc. /Old/.
He received his undergraduate degree from the University of California, Davis and a graduate degree from San Francisco State University.